Cardiac and great vessel thrombosis in Behçet's disease

Internal Medicine

Volumn 40, Issue 1, 2001, Pages 68-72

  Özatli, Düzgun ^a,b   Kav, Taylan ^a   Haznedaroǧlu, Ibrahim C ^a   Büyükaşik, Yahya ^a   Koşar, Ali ^a   Özcebe, Osman ^a   Dündar, Semra V ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Ilk Yerle im Mahallesi   (Turkey)

Author keywords

Beh et's disease; Cardiac involvement; Interferon treatment; Vascular involvement

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; APHTHOUS STOMATITIS; ARTICLE; AXILLARY VEIN; BACTERIAL ENDOCARDITIS; BEHCET DISEASE; BLOOD; CASE REPORT; DRUG COMBINATION; ERYTHEMA NODOSUM; FIBRINOLYTIC THERAPY; HEART ATRIUM; HEART DISEASE; HEART VENTRICLE; HUMAN; MALE; PATHOLOGY; PULMONARY VEIN; SUPERIOR CAVA VEIN SYNDROME; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS; TRICUSPID VALVE; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

ADULT; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; AXILLARY VEIN; BEHCET SYNDROME; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENDOTHELIUM, VASCULAR; ERYTHEMA NODOSUM; HEART ATRIA; HEART DISEASES; HEART VENTRICLES; HEPARIN; HUMANS; MALE; PULMONARY VEINS; STOMATITIS, APHTHOUS; STREPTOKINASE; SUPERIOR VENA CAVA SYNDROME; THROMBECTOMY; THROMBOLYTIC THERAPY; THROMBOPHILIA; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TRICUSPID VALVE; VENOUS THROMBOSIS; WARFARIN;

EID: 0035218639     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.68     Document Type: Article

References (31)

1. Behçet H. Uber rezidivierende aphtose, durch ein virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105: 1152-1157, 1937.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's Disease. N Engl J Med 341: 1284-1291, 1999.
3. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet's Disease. Semin Arthritis Rheum 27: 197-217, 1998.
4. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's Disease. Lancet 335: 1078-1080, 1990.
5. Lakhanpal S, Tant K, Lie JT, Katoh K. Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 16: 790-799, 1985.
6. Studd M, McCance DJ, Lehner T. Detection of HSV-I DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers of the polymerase chain reaction. J Med Microbiol 34: 39-43, 1991.
7. Niwa Y, Mizushima Y. Neutrophil-polentiating factors released from stimulated lymphocytes: special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's Disease. Clin Exp Immunol 79: 353-360, 1990.
8. Koç Y, Güllü I, Akpek G, et al. Vascular involvement in Behçet's Disease. J Rheumatol 19: 402-410, 1992 (see comments).
9. Dilşen N, Konice K, Aral O, Ocal L, Inane M, Gul A. Risk factors for vital organ involvement in Behçet's Disease, in: Godeau P, Wechsler B, Eds. Behçet's disease. Elsevier Science, New York, 1993: 165-169.
10. Chamberlian MA, Hampton KK, Menon D, Davies JA. Coagulation and fibrinolytic activity in Behçel's disease, in: O'Duffy JD, Kokmen E, Eds. Behçet's Disease: Basic and Clinical Aspects. Mayo Clinic, Rochester, 1991: 541-544.
11. Ozcebe Oİ, Özdemir O, Dündar SV, Kirazli Ş. Impaired F. VIII: C release to intravenous 1-deamino-8-D arginine vasopressin in Behçet's disease: a clue for endothelial dysfunction? in: Godeau P, Wechsler B, Eds. Behçet's Disease. Elsevier Science, Paris 1993: 123-126.
12. Haznedaroǧlu IC, Ozdemir O, Ozcebe O, Dündar SV, Kirazli Ş. Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75: 974-975, 1996 (letter).
13. Özcebe O, Haznedaroǧlu IC, Özdemir O, Saylnalp NM, Dündar SV, Kirazli Ş. Soluble thrombomodulin and fibrinolysis in Behçet's disease. Med Principl Pract 5: 146-150, 1996.
14. Haznedaroǧlu IC, Dündar S, Kirazh S. Eicosanoids in the prethrombotic state of Behçet's disease. Thromb Res 80:445-446, 1995 (letter).
15. Haznedaroǧlu IC, Ozcebe O, Çelik I, Dündar SV, Kirazhi S. Haemostatic marker of procoagulant imbalance in Behçet's disease. Eur J Haematol 57: 107-108, 1996.
16. Haznedaroǧlu IC, Ozcebe O, Ozdemir O, Çelik I, Dündar SV, Kirazli S. Impaired heamostatic kinetics and endothelial function in Behçet's disease. J Intern Med 240: 181-187, 1996.
17. Sanchez-Burson J, Corzo JE, Marenco JL, Rejon-Gieb E. Trombolytic therapy in pulmonary embolism of Behçet's disease. Acta Haematol 96: 181-183, 1996 (see comments).
18. Hampton KK, Chamberlain MA, Menon DK, Davies JA. Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost 66: 292-294, 1991.
19. Mishima H, Masuda K, Shimada S, Toki N, Tsushima H, Gocho M. Plasminogen activator activity levels in patients with Behçet's syndrome. Arch Ophthalmol 103: 935-936, 1985.
20. James G, Thomson A. Recognition of the diverse cardiovascular manifestations in Behçet's disease. Am Heart J 103: 457-458, 1982.
21. Valesini Pezzi P, Catarinelli G, et al. Behçet's Disease, in: O'Duffy J, Kökmen E Eds. Basic and clinical aspects. Marcel Dekker, Minnesota, 1991: 279-299.
22. Dündar S, Ünal S, Sivri B, et al. Recent advances in Behçet's disease, in: Lehler T, Barnes CG, Eds. Royal Society of Medicine Services, London, 1986: 216-221.
23. Gürler A, Çaǧlar N, Erol Ç, et al. Behçet's Disease, in: O'Duffy J, Kökmen E, Eds. Basic and clinical aspects. Marcel Dekker, Minnesota, 1991: 187-190.
24. Ioakimidis D, Georganas C, Panagoulis C, et al. A case of Adamantides-Behçet's syndrome presenting as myocardial infarction. Clin Exp Rheumatol 23: 323-327, 1996.
25. Hamuryudan V, Yurdakul S, Kural Ar, Inuce U, Yazlcl H. Diffuse proliferative glomerulonephritis in Behçet's syndrome. Br J Rheumatol 30: 63-64, 1991.
26. Davis JD. Behçet's syndrome with hemoptysis and pulmonary lesions. J Pathol 109: 351-356, 1973.
27. Lie JT. Cardiac and pulmonary manifestation of Behçet's syndrome. Path Res Pract 183: 347-355, 1988.
28. O'Duffy JD. Vasculitis in Behçet's disease. Rheumat Dis Clin North Am 16: 423-431, 1990.
29. Hamuryudan V, Ozdoǧan H, Yazlcl H. Other forms of vasculitis and pseudovasculitis. In: Vasculitis. Baillieres Clin Rheumatol 11: 335-355, 1997.
30. Çallşkan S, Eldem B, Demiroǧlu H, Yaylali V, Özcebe OI., Dündar S. Interferon alpha-2b in the treatment of ocular Behçet's disease. Middle East J Opht 3: 94-99, 1995.
31. 2 receptor, interleukin-2, interleukin-2 receptor and E-selectin in Behçet's disease. Rheumatol Int 19: 11-14, 1999.